Supplements
MagMind scores well due to its unique Magnesium L-Threonate form, which preclinical data shows crosses the blood-brain barrier effectively, supported by human RCTs at matching doses (1-2g/day) showing sleep improvements (e.g., PMID 39252819: +deep/REM sleep, mood) and modest cognition gains (PMID 41601871: NIH cognition composite p=0.043). However, effectiveness tempered by low evidence rating from Examine (industry-funded, unvalidated outcomes) and ConsumerLab (minimal cognition benefit), limit
MagMind is a good option for those seeking brain-targeted magnesium support, particularly for sleep and mild cognition benefits backed by emerging RCTs. Best for short-term use; combine with lifestyle factors. Consult doctor if on meds.